Skip to main content

Table 1 Findings for hepato-renal function, lipid metabolism, and autoimmune disease parameters in a patient with multiple symmetric lipomatosis

From: A case report of Multiple Symmetric Lipomatosis (MSL) in an East Asian Female

 

Parameter

Case

Normal range

Min.

Max.

Unit

Autoimmune disease

ANA

Negative

   

Anti-CCP

Negative

   

RF

7.32

0

  

ESR

3

1

10

mm/h

CRP

0.08

0

0.3

mg/dL

Renal function

BUN

15.5

8

23

mg/dL

Creatinine

1.3

0.6

1.2

mg/dL

Liver function

Glucose

178

70

110

mg/dL

T.PRO

5.1

5.8

8

g/dL

Albumin

2.4

3.1

5.2

g/dL

r-GTP

104

0

40

IU/L

D.Bil

1.76

0

0.3

mg/dL

T.Bil

2.54

0

1.2

mg/dL

PT (INR)

1.46

0.89

1.09

 

aPTT

41

26

38

%

Platelet count

78 k

150 k

380 k

/μL

AST (GOT)

85

10

40

IU/L

ALT (GPT)

20

5

40

IU/L

ALP

140

35

129

IU/L

Lipid metabolism

Total cholesterol

50

0

200

mg/dL

HDL cholesterol

10.2

35

65

mg/dL

LDL cholesterol

31

77

135

mg/dL

Triglycerides

1029

50

200

mg/dL

Others

Calcium

8.5

8.5

10.5

mg/dL

Phosphorus

1.6

2.5

5.5

mg/dL

Uric acid

10

2.5

8.3

mg/dL

  1. ANA: Antinuclear antibody, Anti-CCP: Anti-citrullinated peptides, RF: Rheumatic factor, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, BUN: Blood urea nitrogen, T.PRO: Total protein, r-GTP: R-glutamyl transpeptidase, D.Bil: Direct bilirubin, T.Bil: Total bilirubin, PT: Prothrombin time, aPTT: Activated partial thromboplastin time, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, ALP: Alkaline phosphatase